Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F5UO
|
||||
Former ID |
DIB004628
|
||||
Drug Name |
KMS-88009
|
||||
Synonyms |
KMS-88009; KMS-88016; KMSB-600; Aminostyrylbenzofuran derivative beta amyloid fibril formation inhibitors (Alzheimer's disease), Korea Institute of Science and Technology/Seoul National University/Hanmi Pharmaceutical
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Investigative | [543619] | ||
Company |
Korea Institute of Science and Technology
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1c(cc2c(c1)cc(o2)/C=C/c1ccc(cc1)N(C)C)OC
|
||||
Target and Pathway | |||||
Target(s) | Amyloid beta A4 protein | Target Info | Inhibitor | [543619] | |
KEGG Pathway | Notch signaling pathway | ||||
Alzheimer's disease | |||||
Reactome | Nuclear signaling by ERBB4 | ||||
Degradation of the extracellular matrix | |||||
Regulated proteolysis of p75NTR | |||||
NRIF signals cell death from the nucleus | |||||
Activated NOTCH1 Transmits Signal to the Nucleus | |||||
Constitutive Signaling by NOTCH1 PEST Domain Mutants | |||||
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |||||
EPH-ephrin mediated repulsion of cells | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.